MTH1 as a Chemotherapeutic Target: The Elephant in the Room

Author： Samaranayake Govindi J.   Huynh Mai   Rai Priyamvada  

Publisher： MDPI

E-ISSN： 2072-6694|9|5|47-47

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.5, 2017-05, pp. : 47-47

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer

By Li Le-chen   Liu Guo-dong   Zhang Xin-jie   Li Yan-bo  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 439-449

Springer Publishing Company

Access to resources Recommend Favorite

The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?

By Purow Benjamin  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 429-436

Springer Publishing Company

Access to resources Recommend Favorite

Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice

By Allegrini Giacomo   Goulette Frederick   Darnowski James   Calabresi Paul  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition - identification of novel chemotherapeutic drug resistance modulators

By Touhey S.   O'Connor R.   Plunkett S.   Maguire A.   Clynes M.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1661-1670

Elsevier

Access to resources Recommend Favorite

FoxM1: a potential drug target for glioma

By Li Yu   Zhang Sicong   Huang Suyun  

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 223-226

Future Medicine

Access to resources Recommend Favorite